A Comprehensive Supply Chain for Core Intermediates in Diabetes Treatment
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
March 6, 2026
N-[(1R)-2-[1,1'-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester
LCZ696 intermediate; tert-butyl (R)-(1-([1,1′-biphenyl]-4-yl)-3-hydroxypropan-2-yl)carbamate
CAS:1426129-50-1
Chemical Formula:C20H25NO3
MW:327.42
Availability: R&D; Commercialization
N-[(1R)-2-[1,1'-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester
⬤ CAS No.1426129-50-1
⬤ Packaging type：20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| English Name | N-[(1R)-2-[1,1′-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester |
| CAS No. | 1426129-50-1 |
| Chemical Formula | C20H25NO3 |
| Molecular Weight | 327.42 |
Related Categories | LCZ696 intermediate; reference substance-impurity reference substance; medical raw material; antihypertensive; impurity reference substance; LCZ696; LCZ 696 |
| Mol | 1426129-50-1.mol |
| Boiling point | 514.5±50.0 °C(Predicted) |
| Density | 1.103±0.06 g/cm3(Predicted) |
| Storage conditions | 2-8°C |
| Acidity coefficient (pKa) | 11.85±0.46(Predicted) |
| InChIKey | TYQICOFAZDVKMK-GOSISDBHSA-N |
| SMILES | C(OC(C)(C)C)(=O)N[C@@H](CO)CC1=CC=C(C2=CC=CC=C2)C=C1 |
| Product name | N-[(1R)-2-[1,1′-Biphenyl]-4-yl-1-(hydroxymethyl)ethyl]carbamic acid 1,1-dimethylethyl ester |
| Molecular formula | C20H25NO3 |
| Skin contact | Immediately flush with plenty of clean water. |
| Eye contact | Immediately flush with plenty of clean water and seek medical attention. |
| Inhalation | Move to fresh air, seek medical attention immediately if you feel unwell. |
| Ingestion | Do not induce vomiting, seek medical attention immediately. |
| Personal protection | Wear chemical protective clothing, gloves, goggles, etc. |
| Leakage treatment | Use sand, inert absorbent, or other suitable substances to absorb the leaked material and transfer it to a safe container. |
| Environmental protection | Prevent the leaked material from entering the sewer, water bodies, etc. |
| Storage conditions | Store in a dry, cool, well-ventilated place, away from fire and heat sources. |
| Transportation precautions | Comply with relevant transportation regulations and avoid mixing with incompatible materials. |
| Disposal method | Comply with relevant disposal regulations and avoid mixing with incompatible materials. |
| Uses | LCZ696 intermediate is a useful intermediate for the preparation of sabibil (S080900)/valsartan (V095750). |
Applications | LCZ696 intermediate is an intermediate for organic synthesis and pharmaceutical research and development. It is mainly used as an organic intermediate and a pharmaceutical intermediate. It can be used in laboratory research and development processes and chemical pharmaceutical synthesis processes. It can be used for the synthesis of the raw material drug LCZ696. |
Customer Reviews
Real customer feedback
Alexandra Thompson
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Ethan Lee
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Sophia Chen
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Lucas Rodriguez
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
What's News
Latest news at Tianming
CDMO vs. Direct Manufacturer: Which Model Fits Your API Strategy?
Drawing from on-the-ground experience in China’s top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when to buy from the workhorses of mature production.
March 3, 2026
Case Study: Improving Yield & Purity Through Route Optimization
This case study, based on publicly available academic literature and patents, focuses on the application of synthetic route optimization in improving the yield and purity of Active Pharmaceutical Ingredients (APIs).
February 27, 2026
Still Have Questions？
If you still have questions or need more information, our team is here to help. Please don’t hesitate to contact us for personalized assistance.